December 9, 2021

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, NE

Washington, D.C. 20549

 

RE: BiomX Inc.  
  Registration Statement on Form S-3  
  File No. 333-261419  

 

Dear Sir or Madam:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BiomX Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on December 13, 2021, or as soon as practicable thereafter.

  

The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Howard E. Berkenblit of Sullivan & Worcester LLP at (617) 338-2979 and that such effectiveness also be confirmed in writing.

 

[Signature page follows]

 

 

United States Securities and Exchange Commission

December 9, 2021

Page 2

 

  Very truly yours,
   
  BiomX Inc.
   
  By:  /s/ Marina Wolfson
    Name: Marina Wolfson
    Title: Senior Vice President for Finance and Operations

 

 

Signature Page to Acceleration Request